We observed that the selective knockdown of ULK1, Atg5, or Atg7 or pharmacological inhibition of autophagy with 3MA increased the levels of active caspase 3, 7 and PARP degradation in WIN55,212-2-treated LN18 glioma cells. This evidence concerns the gene ATG5 and central nervous system cancer.